Safeguarding Success: How to Minimize Risks in Your Launch Strategy
November 27, 2025
The pharma field sees launches as key. Launches set brand paths. A
- April 1, 2026
Product launches and go-to-market strategy
The pharma field sees launches as key. Launches set brand paths. A
Sofinnova Partners, a key player in the European venture capital arena, has
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS)
Supernus Pharmaceuticals has recently hit the brakes on new deliveries of its
The introduction of TrumpRx.gov marks a pivotal moment in the healthcare industry,
In the ever-evolving biopharmaceutical landscape, Eli Lilly has taken center stage with
The biotech industry is currently experiencing a significant surge, with companies capitalizing
The biopharmaceutical landscape is on the cusp of a technological revolution, with
In a significant shift within the biopharmaceutical landscape, I-Mab Biopharma has officially
Roche continues to solidify its position as a leader in oncology with
In a significant move to alleviate the financial burden of diabetes management,
Navigating the complex landscape of FDA regulations can be daunting for biopharmaceutical
In a transformative move for the biotech industry, AstraZeneca has made headlines
Excellergy, an innovative biotech company located in the San Francisco Bay Area,
In a significant development within the pharmaceutical industry, the U.S. Food and
The biopharma industry is known for its dynamic landscape and the groundbreaking
AstraZeneca’s recent commitment of billions of dollars to establish a cutting-edge active
In a landscape where innovation is met with both opportunity and challenges,
The Centers of Excellence in Regulatory Science and Innovation (CERSI) program has
